APA (7th ed.) Citation

Yildirim, S., Dogan, A., Akdag, G., Cavdar, E., Kinikoglu, O., Oksuz, S., . . . Turan, N. (2024). A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers, 16(14), 2512. https://doi.org/10.3390/cancers16142512

Chicago Style (17th ed.) Citation

Yildirim, Sedat, et al. "A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients." Cancers 16, no. 14 (2024): 2512. https://doi.org/10.3390/cancers16142512.

MLA (9th ed.) Citation

Yildirim, Sedat, et al. "A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients." Cancers, vol. 16, no. 14, 2024, p. 2512, https://doi.org/10.3390/cancers16142512.